Saratoga Investment's Credit Quality Streak May Finally Reveal What It's Been Hiding

Saratoga Investment Corp. (SAR) is set to report fiscal fourth quarter 2026 earnings on May 5, 2026, after market close, with analysts expecting $0.53 per share—a sharp decline from the $0.90 posted in the same quarter last year. The central question: can this business development company stabilize earnings after a year of significant compression, or will the downward trajectory continue into fiscal 2027? With the stock trading at $23.89 and analysts projecting further year-over-year declines, this report will test investor confidence in SAR's ability to navigate a challenging credit environment.

Part 1: Earnings Preview

Saratoga Investment Corp. is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses, investing primarily in senior and unitranche leveraged loans, mezzanine debt, and equity. As a business development company (BDC), it generates returns through current income and capital appreciation from its debt and equity investments.

SAR is scheduled to report fiscal Q4 2026 results on May 5, 2026, after the close, with a conference call the following day. Analysts expect $0.53 per share, down from $0.61 reported in the most recent quarter (Q3 2026, ended November 30, 2025). Year-over-year, the consensus represents a 41.1% decline from the $0.90 earned in Q4 2025, underscoring the sharp earnings compression the company has faced. Revenue estimates stand at $30.82 million for the quarter, down 1.5% from $31.3 million in the prior-year period.

Three key themes define this earnings story:

Credit Quality and Portfolio Performance: Investors will scrutinize non-accrual rates, portfolio valuations, and any signs of stress in SAR's middle-market loan book. With earnings down sharply year-over-year, the health of underlying investments and any reserve builds or write-downs will be critical indicators of whether the worst is behind the company or if further deterioration lies ahead.

Net Investment Income Trajectory: The consensus projects continued pressure on net investment income (NII), the lifeblood of BDC earnings. Management's commentary on interest rate sensitivity, portfolio yield, and funding costs will shape expectations for fiscal 2027, where analysts already forecast another 3.4% decline in EPS to $2.30.

Capital Deployment and Dividend Sustainability: SAR recently priced a $100 million public offering of 7.50% notes due 2031 in January 2026, providing fresh capital for deployment. Investors will want clarity on how management plans to put this capital to work, whether origination pipelines are improving, and—critically—whether the current dividend (recently declared at $0.75 per share for Q1 fiscal 2027, paid monthly at $0.25) remains sustainable given the earnings outlook.

Analyst commentary ahead of the release reflects caution. The consensus rating sits at 3.22 (Hold), with only one Strong Buy against eight Hold ratings. The mean price target of $23.62 implies minimal upside from current levels, suggesting the Street is waiting for evidence of stabilization before turning more constructive.

Part 2: Historical Earnings Performance

Saratoga Investment has struggled with estimate accuracy over the past year, missing consensus in three of the last four quarters. The most recent quarter (Q3 2026, November 2025) provided a rare bright spot with a 3.39% beat, reporting $0.61 versus the $0.59 estimate. However, this followed a string of disappointing results: Q2 2026 missed by 13.43% ($0.58 vs. $0.67 expected), Q1 2026 missed by 4.35% ($0.66 vs. $0.69), and Q4 2025 delivered the most severe shortfall at 27.27% ($0.56 vs. $0.77).

The pattern reveals a company whose earnings have consistently undershot expectations, with the magnitude of misses particularly pronounced in the first half of fiscal 2026. While the most recent quarter's modest beat offers some hope, the trend remains concerning—actual EPS has declined sequentially from $0.66 to $0.58 to $0.61 over the past three quarters, even as the company briefly exceeded lowered estimates. The year-over-year comparisons are even starker: Q3 2026's $0.61 represents a 32.2% decline from the $0.90 reported in Q3 2025, illustrating the sustained pressure on profitability.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

SAR typically reports after market close, meaning Day 0 reflects anticipatory trading before results are known, while Day +1 captures the market's first full reaction to the actual numbers.

Historical price behavior around earnings shows moderate volatility, with the stock averaging a 1.62% absolute move on announcement day and a larger 3.44% move the following session. The Day +1 reaction tends to be more pronounced, consistent with after-hours reporting where the full market response unfolds the next trading day.

Recent quarters show mixed directional patterns. The most recent report (January 2026) saw a 2.59% decline on Day 0 followed by a 1.55% recovery on Day +1, suggesting initial disappointment gave way to more measured assessment. The October 2025 report triggered sharper selling—down 4.34% on Day 0 and another 4.71% on Day +1—reflecting the market's negative reaction to the 13.43% earnings miss. The most dramatic move came after May 2025's report, when the stock dropped 7.94% on Day +1 following the severe 27.27% earnings miss.

The average Day +1 range of 4.06% indicates investors should prepare for meaningful price swings as the market digests results and management commentary. Given the pattern of larger Day +1 moves, the conference call on May 6 will likely prove as important as the initial numbers in determining the stock's direction.

Part 2.2: Options Market Expected Move

The options market is pricing a 4.98% expected move through the May 15 expiration (11 days out), implying a range of $22.70 to $25.08. This sits above the historical 3.44% average Day +1 move but below the 4.06% average Day +1 range, suggesting options traders are anticipating volatility roughly in line with—or slightly elevated versus—recent earnings reactions. The elevated implied volatility of 36.87% reflects heightened uncertainty around this report.

Part 3: What Analysts Are Saying

Analyst sentiment on SAR remains cautious, with the consensus rating at 3.22 (Hold) and an average price target of $23.62—just 1.1% below the current price of $23.89. The rating breakdown shows 1 Strong Buy, 0 Moderate Buys, 8 Holds, 0 Moderate Sells, and 0 Strong Sells across 9 analysts covering the stock. Price target estimates range from a low of $23.00 to a high of $25.00, a relatively tight band that suggests limited conviction in either direction.

Sentiment has remained unchanged over the past month, with the rating distribution and average recommendation holding steady at 3.22. This stability reflects a Street in wait-and-see mode—analysts appear unwilling to upgrade ahead of evidence that earnings have bottomed, but equally reluctant to downgrade given the stock's already-compressed valuation and high dividend yield. The lack of any Sell ratings indicates analysts aren't calling for further significant downside, but the dominance of Hold ratings (89% of coverage) signals skepticism about near-term upside catalysts.

The consensus price target's minimal discount to the current price implies the market has largely priced in the expected earnings weakness. For the stock to break out of this range, SAR would likely need to deliver a meaningful positive surprise on either earnings quality, forward guidance, or dividend sustainability—none of which the current analyst positioning suggests is anticipated.

Part 4: Technical Picture

SAR enters earnings with improving technical momentum after a period of weakness. The Barchart Technical Opinion currently shows a Buy signal at 8%, a dramatic reversal from the Sell signal at 88% just one week ago and the Sell signal at 88% a month ago. This sharp shift suggests recent price action has triggered a technical inflection point, though the low 8% reading indicates the buy signal remains tentative.

Timeframe Analysis:

• Short-term (Hold): Neutral reading suggests the immediate trend lacks strong directional conviction despite the recent signal flip
• Medium-term (50% Sell): Moderate sell signal indicates lingering weakness in the intermediate timeframe that hasn't fully resolved
• Long-term (50% Buy): Moderate buy signal reflects underlying support in the longer-term trend structure

Trend Characteristics: The combination of Minimum strength and Average direction points to a trend environment lacking conviction—the stock is attempting to establish upward momentum but hasn't yet generated the follow-through needed to confirm a sustainable reversal.

The stock is trading at $23.89, positioned above all major moving averages: the 5-day ($23.25), 10-day ($22.93), 20-day ($22.78), 50-day ($22.64), 100-day ($22.95), and 200-day ($23.36). This clean technical setup—with price above the entire moving average stack—provides a supportive backdrop heading into earnings.

The 200-day moving average at $23.36 represents the key technical level to watch—the stock is trading just 2.3% above this long-term trend line, making it critical support if results disappoint. The recent breakout above shorter-term averages suggests accumulation ahead of the report, but the Minimum strength characterization warns that conviction remains fragile. A beat-and-raise scenario could trigger a breakout toward the $25.00 high-end price target, while a miss risks a quick retreat back toward the 50-day average at $22.64. The technical setup is cautiously constructive but lacks the momentum to absorb a significant negative surprise.